The meeting brought together over 200 specialists from 25 countries, representing a truly international effort to advance research and clinical practice in the field of kidney diseases associated with monoclonal gammopathies.
The scientific programme featured a rich series of sessions addressing key areas in the field, including new pathophysiological insights into monoclonal gammopathies and kidney disease, innovations in diagnostic tools and biomarkers, emerging therapeutic strategies, and the latest updates from ongoing clinical trials.
In addition to lectures and roundtable discussions, the programme included oral and poster presentations, showcasing submitted cutting-edge research from participants. To highlight and encourage scientific excellence, the IKMG Scientific Prizes were awarded to the top three abstracts.
The Champalimaud Foundation’s riverside auditorium provided an inspiring setting for scientific exchange, networking, and collaboration.
The International Kidney and Monoclonal Gammopathy Research Group (IKMG) is a multidisciplinary network of nephrologists, haematologists, pathologists, and other specialists dedicated to the study, diagnosis, and treatment of kidney diseases linked to monoclonal gammopathies, including amyloidosis, light chain deposition disease, and related disorders.
Through international meetings such as this one, the IKMG fosters collaboration, shares knowledge, and contributes to advancing patient care worldwide.
